Status:
RECRUITING
Long Term Effects of Awake Prone Positioning in COVID-19 ICU Patients
Lead Sponsor:
University Hospital, Tours
Conditions:
SARS-CoV 2 Pneumonia
Eligibility:
All Genders
18+ years
Brief Summary
Long term follow up of patients included in a randomized controlled trial evaluating awake prone positioning among patients suffering SARS-CoV2 pneumonia (NCT04358939)
Detailed Description
All patients included in the initial trial who survived and were not lost to follow up at 28 days will be invited for a telephone interview to collect data on long term quality of life.
Eligibility Criteria
Inclusion
- Patients included in the randomized meta-trial evaluating awake prone position versus control among COVID-19 patients on high-flow nasal oxygen therapy (Ehrmann 2021).
- Patients alive at D28
- No opposition to participate in the research which evaluates mortality and quality of life by telephone interview.
Exclusion
- Patients lost to follow-up after 28 days.
- Withdrawal of consent from randomized meta-trial by patient
- Vulnerable person: safeguard of justice, curatorship, or guardianship
- Patients refusing to answer telephone questionnaire.
Key Trial Info
Start Date :
May 3 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT06080737
Start Date
May 3 2024
End Date
December 1 2025
Last Update
May 29 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
university hospital Tours
Tours, France, 37000